These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 32978487)
1. Whey protein isolate inhibits hepatic FGF21 production, which precedes weight gain, hyperinsulinemia and hyperglycemia in mice fed a high-fat diet. Nonogaki K; Kaji T Sci Rep; 2020 Sep; 10(1):15784. PubMed ID: 32978487 [TBL] [Abstract][Full Text] [Related]
2. Pharmacologic inhibition of serotonin htr2b ameliorates hyperglycemia and the altered expression of hepatic FGF21, Sdf2l1, and htr2a in db/db mice and KKA Nonogaki K; Kaji T Heliyon; 2020 Dec; 6(12):e05774. PubMed ID: 33364514 [TBL] [Abstract][Full Text] [Related]
3. The Regulatory Role of the Central and Peripheral Serotonin Network on Feeding Signals in Metabolic Diseases. Nonogaki K Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163521 [TBL] [Abstract][Full Text] [Related]
4. Diminished diet-induced hyperglycemia and dyslipidemia and enhanced expression of PPARalpha and FGF21 in mice with hepatic ablation of brain-derived neurotropic factor. Teillon S; Calderon GA; Rios M J Endocrinol; 2010 Apr; 205(1):37-47. PubMed ID: 20097691 [TBL] [Abstract][Full Text] [Related]
5. Hepatocyte-specific fibroblast growth factor 21 overexpression ameliorates high-fat diet-induced obesity and liver steatosis in mice. Yano K; Yamaguchi K; Seko Y; Okishio S; Ishiba H; Tochiki N; Takahashi A; Kataoka S; Okuda K; Liu Y; Fujii H; Umemura A; Moriguchi M; Okanoue T; Itoh Y Lab Invest; 2022 Mar; 102(3):281-289. PubMed ID: 34732847 [TBL] [Abstract][Full Text] [Related]
6. Dietary medium-chain fatty acids reduce hepatic fat accumulation via activation of a CREBH-FGF21 axis. Cao Y; Araki M; Nakagawa Y; Deisen L; Lundsgaard A; Kanta JM; Holm S; Johann K; Brings Jacobsen JC; Jähnert M; Schürmann A; Kiens B; Clemmensen C; Shimano H; Fritzen AM; Kleinert M Mol Metab; 2024 Sep; 87():101991. PubMed ID: 39019116 [TBL] [Abstract][Full Text] [Related]
7. Chronic high-sucrose diet increases fibroblast growth factor 21 production and energy expenditure in mice. Maekawa R; Seino Y; Ogata H; Murase M; Iida A; Hosokawa K; Joo E; Harada N; Tsunekawa S; Hamada Y; Oiso Y; Inagaki N; Hayashi Y; Arima H J Nutr Biochem; 2017 Nov; 49():71-79. PubMed ID: 28886439 [TBL] [Abstract][Full Text] [Related]
8. Dietary Cyanidin-3-Glucoside Attenuates High-Fat-Diet-Induced Body-Weight Gain and Impairment of Glucose Tolerance in Mice via Effects on the Hepatic Hormone FGF21. Tian L; Ning H; Shao W; Song Z; Badakhshi Y; Ling W; Yang BB; Brubaker PL; Jin T J Nutr; 2020 Aug; 150(8):2101-2111. PubMed ID: 32470979 [TBL] [Abstract][Full Text] [Related]
9. Fgf21 impairs adipocyte insulin sensitivity in mice fed a low-carbohydrate, high-fat ketogenic diet. Murata Y; Nishio K; Mochiyama T; Konishi M; Shimada M; Ohta H; Itoh N PLoS One; 2013; 8(7):e69330. PubMed ID: 23874946 [TBL] [Abstract][Full Text] [Related]
10. Whey-reduced weight gain is associated with a temporary growth reduction in young mice fed a high-fat diet. Tranberg B; Madsen AN; Hansen AK; Hellgren LI J Nutr Biochem; 2015 Jan; 26(1):9-15. PubMed ID: 25315863 [TBL] [Abstract][Full Text] [Related]
11. Hepatic Fat Content Is Associated with Fasting-Induced Fibroblast Growth Factor 21 Secretion in Mice Fed Soy Proteins. Taniguchi H; Akiyama N; Ishihara K J Nutr Sci Vitaminol (Tokyo); 2019; 65(6):515-525. PubMed ID: 31902865 [TBL] [Abstract][Full Text] [Related]
12. Increased fibroblast growth factor 21 expression in high-fat diet-sensitive non-human primates (Macaca mulatta). Nygaard EB; Møller CL; Kievit P; Grove KL; Andersen B Int J Obes (Lond); 2014 Feb; 38(2):183-91. PubMed ID: 23736354 [TBL] [Abstract][Full Text] [Related]
13. Fibroblast Growth Factor 21 (Fgf21) Gene Expression Is Elevated in the Liver of Mice Fed a High-Carbohydrate Liquid Diet and Attenuated by a Lipid Emulsion but Is Not Upregulated in the Liver of Mice Fed a High-Fat Obesogenic Diet. Hao L; Huang KH; Ito K; Sae-Tan S; Lambert JD; Ross AC J Nutr; 2016 Feb; 146(2):184-90. PubMed ID: 26764334 [TBL] [Abstract][Full Text] [Related]
14. Hepatic PTP4A1 ameliorates high-fat diet-induced hepatosteatosis and hyperglycemia by the activation of the CREBH/FGF21 axis. Hwang B; Kwon MG; Cho MJ; Lee NK; Lee J; Lee JW; Oh KJ; Bae KH; Hwang JH; Min JK; Park JG Theranostics; 2023; 13(3):1076-1090. PubMed ID: 36793871 [TBL] [Abstract][Full Text] [Related]
15. Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1α-FGF21 axis in mice. Aljohani A; Khan MI; Bonneville A; Guo C; Jeffery J; O'Neill L; Syed DN; Lewis SA; Burhans M; Mukhtar H; Ntambi JM J Biol Chem; 2019 Dec; 294(51):19475-19485. PubMed ID: 31690632 [TBL] [Abstract][Full Text] [Related]
16. Cellular mechanisms by which FGF21 improves insulin sensitivity in male mice. Camporez JP; Jornayvaz FR; Petersen MC; Pesta D; Guigni BA; Serr J; Zhang D; Kahn M; Samuel VT; Jurczak MJ; Shulman GI Endocrinology; 2013 Sep; 154(9):3099-109. PubMed ID: 23766126 [TBL] [Abstract][Full Text] [Related]
17. Hepatocyte-specific GDF15 overexpression improves high-fat diet-induced obesity and hepatic steatosis in mice via hepatic FGF21 induction. Takeuchi K; Yamaguchi K; Takahashi Y; Yano K; Okishio S; Ishiba H; Tochiki N; Kataoka S; Fujii H; Iwai N; Seko Y; Umemura A; Moriguchi M; Okanoue T; Itoh Y Sci Rep; 2024 Oct; 14(1):23993. PubMed ID: 39402176 [TBL] [Abstract][Full Text] [Related]
18. GLP-1-derived nonapeptide GLP-1(28-36)amide inhibits weight gain and attenuates diabetes and hepatic steatosis in diet-induced obese mice. Tomas E; Wood JA; Stanojevic V; Habener JF Regul Pept; 2011 Aug; 169(1-3):43-8. PubMed ID: 21549160 [TBL] [Abstract][Full Text] [Related]
19. Methionine restriction prevents onset of type 2 diabetes in NZO mice. Castaño-Martinez T; Schumacher F; Schumacher S; Kochlik B; Weber D; Grune T; Biemann R; McCann A; Abraham K; Weikert C; Kleuser B; Schürmann A; Laeger T FASEB J; 2019 Jun; 33(6):7092-7102. PubMed ID: 30841758 [TBL] [Abstract][Full Text] [Related]
20. Whey peptides exacerbate body weight gain and perturb systemic glucose and tissue lipid metabolism in male high-fat fed mice. D'Souza K; Acquah C; Mercer A; Paudel Y; Pulinilkunnil T; Udenigwe CC; Kienesberger PC Food Funct; 2021 Apr; 12(8):3552-3561. PubMed ID: 33900305 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]